Tomball

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Asthma3 trials
• Fatty liver disease (MASLD/MASH)2 trials

Phase

• Phase 35 trials
• Phase 1/21 trial

Status

• Recruiting4 trials
• Completed2 trials

Lead sponsor

• GlaxoSmithKline6 trials

Running trials

• Recruiting

  A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

  NCT07645248· Phase 3· GlaxoSmithKline· Source

  Contact: Mustafa Naeem (principal investigator)

• Recruiting

  A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)

  NCT07782996· Phase 3· GlaxoSmithKline· Source

  Contact: Mustafa Naeem (principal investigator)

• Recruiting

  A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

  NCT07221188· Phase 3· GlaxoSmithKline· Source

  Contact: Muhammad Irfan (principal investigator)

• Recruiting

  A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

  NCT07221227· Phase 3· GlaxoSmithKline· Source

  Contact: Muhammad Irfan (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma2 recruiting
• Fatty liver disease (MASLD/MASH)2 recruiting

Closed trials

• Completed

  A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma

  NCT06261957· Phase 3· GlaxoSmithKline· Source

• Completed

  A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

  NCT05496231· Phase 1/2· GlaxoSmithKline· Source